Health

Ciara Shares Progress in Her 70-Pound Weight Loss Journey

Apr 27, 2024 1 min read

Jump to Summary

Ciara, the Grammy-winning singer and performer, is publicly documenting her postpartum weight loss journey after giving birth to her fourth child. She took to Instagram to share with her followers that she is aiming to lose 70 pounds. In a series of posts, Ciara showed a scale reading 181.4 pounds, alongside images of her health and wellness routine, which included a large jug of water with motivational phrases, as well as her rehearsal space for the upcoming Missy Elliott's Out of This World tour.

The 38-year-old star's weight loss goals coincide with her professional commitments. Ciara shared glimpses of her rehearsal sessions and the prospect of being on tour with notable artists such as Busta Rhymes and Timbaland. The North American leg of the tour is set to kick off on July 4 at Rogers Arena in Vancouver, Canada. Moreover, Ciara has indicated that for the first time, she will be bringing her young children on the road with her.

In addition to focusing on her fitness and career, Ciara also emphasized the challenge of balancing her work with motherhood. She posted a picture holding her four-month-old baby, Amora Princess, in a recording studio, highlighting the multitasking involved in her daily life. Her husband, NFL quarterback Russell Wilson, and children are set to be a part of her journey as she prepares for the tour while managing her various business endeavors. Support from fellow celebrities and friends is evident in the comments on her posts, with encouragement from figures like Gabrielle Union and Holly Robinson Peete.

#entertainment #nutrition #music

Summary

Other news in health

Survey: 1 in 8 U.S. Adults Has Used GLP-1 Drugs Like Ozempic

Recent data from a KFF Health Tracking Poll indicates that approximately 12% of U.S. adults have used a GLP-1 agonist, a class of drugs that includes Wegovy, Ozempic, Zepbound, and Mounjaro. While these medications are often prescribed for weight loss, they are also commonly used to manage diabetes and

Concerted action key to achieving malaria-free future

Malaria remains a pressing public health concern, with 249 million cases and 608,000 deaths reported worldwide in 2022. The Plasmodium parasite, which is transmitted through mosquito bites, has proven difficult to combat due to its complex nature, drug resistance, and challenges in vector control. Surveillance and diagnostic shortfalls further

Takeda Launches $900M Overhaul to Combat Profit Decline

Takeda Pharmaceutical Company Limited is embarking on a significant restructuring initiative, aiming to bolster its core operating profit margin beyond 30%. This strategic move comes after the company experienced a sharp decline in annual profit, reporting a 54.6% drop to 144.1 billion yen (approximately $863 million) for the

Novo Nordisk Inks $600M Obesity Therapy Deal with Metaphore Biotechnologies

Novo Nordisk has entered into a collaborative agreement with Metaphore Biotechnologies, a company founded by Flagship Pioneering, to develop up to two therapeutic candidates targeting obesity management. The collaboration is set to utilize Metaphore's proprietary MIMICTM technology platform, which focuses on the design of novel compounds that can